Rxo, INC Form 4 insider transactions

RXO, Inc. executive Daniel S. Morris received a grant of 13,377 Restricted Stock Units (RSUs) on May 15, 2026, vesting over three years.

RXO, Inc. CEO Andrew Wilkerson reported transactions involving restricted stock units and common stock, including shares withheld for tax liabilities.

RXO, Inc. CEO Andrew M. Wilkerson reported the vesting of 52,768 Restricted Stock Units, with 22,923 shares withheld for tax obligations.

RXO's Chief Accounting Officer, Jason S. Kerr, reported the vesting of restricted stock units and subsequent tax-related share withholding.

RXO's Chief Financial Officer, James E. Harris, reported the vesting of 12,989 Restricted Stock Units and the withholding of 5,643 shares for tax obligations.

RXO's Chief Legal Officer, Jeffrey D. Firestone, reported the vesting of 11,771 Restricted Stock Units and the withholding of 5,114 shares for tax obligations.

RXO CEO Andrew M. Wilkerson reported the vesting of 52,923 Restricted Stock Units and subsequent tax withholding, resulting in a net increase in direct common stock ownership.

RXO's Chief Legal Officer, Jeffrey D. Firestone, reported the vesting of 8,957 Restricted Stock Units and the withholding of 3,891 shares for tax obligations.

RXO CEO Andrew M. Wilkerson reported the vesting and tax-related disposition of Restricted Stock Units, alongside a new grant of performance-based RSUs.

RXO's Chief Accounting Officer, Jason S. Kerr, reported the vesting of 5,257 Restricted Stock Units and the subsequent withholding of shares for tax obligations.

RXO's Chief Financial Officer, James E. Harris, reported the vesting of restricted stock units and a new performance-based equity award.

RXO's Chief Legal Officer, Jeffrey D. Firestone, reported the vesting of restricted stock units and the grant of new performance-based awards.

RXO, Inc. Director Thomas A. Szlosek was granted 14,517 Restricted Stock Units, vesting in 2027, and deferred 7,745 previously vested units.

RXO, Inc. Director Stephen M. Renna reported the vesting and settlement of Restricted Stock Units and the grant of new RSUs.

RXO, Inc. Director Michelle Nettles was granted 14,517 Restricted Stock Units, which will vest in 2027 and are subject to a deferral election.

RXO Director Mary E. Kissel reported an increase in beneficial ownership of common stock and received a new grant of Restricted Stock Units.

RXO, Inc. Director Adrian Kingshott was granted 14,517 Restricted Stock Units, vesting in 2027, and deferred 7,745 previously vested units.

RXO Director Troy A. Cooper increased his direct common stock ownership by 7,745 shares and received a new grant of 14,517 Restricted Stock Units, vesting in 2027.

RXO Director Christine Breves reported the vesting of 7,745 restricted stock units into common stock and the grant of 14,517 new restricted stock units.

RXO, Inc. Director Troy A. Cooper acquired 8,317 shares of common stock at a weighted average price of $10.61, increasing his beneficial ownership.

RXO Director Adrian Kingshott acquired 9,350 shares of common stock at a weighted average price of $10.75, increasing his direct beneficial ownership.

RXO Director Adrian Kingshott acquired 9,350 common shares at $10.75 each, increasing his total beneficial ownership to 91,137 shares.

RXO's CEO, Andrew M. Wilkerson, reported changes in his beneficial ownership of company stock following the vesting and settlement of Restricted Stock Units.

RXO's Chief Accounting Officer, Jason S. Kerr, sold 33,343 shares of common stock for a weighted average price of $11.57 per share.

RXO Director Thomas A. Szlosek purchased 20,308 shares of common stock and subsequently transferred 49,542 shares into a grantor retained annuity trust, retaining beneficial ownership.

Andrew M. Wilkerson, CEO and Director of RXO, Inc., acquired additional common stock totaling $149,478, demonstrating increased personal investment in the company.

RXO CEO Andrew M. Wilkerson transferred indirect interests in a limited liability company holding company shares to family trusts for estate planning purposes.

RXO's Chief Accounting Officer, Jason S. Kerr, had 9,518 shares withheld by the company to cover tax liabilities related to restricted stock release.

RXO Inc.'s Chief Financial Officer, James E. Harris, reported the vesting of 64,130 Restricted Stock Units and the subsequent withholding of 28,025 shares for tax obligations.

RXO's Chief Legal Officer, Jeffrey D. Firestone, reported the scheduled vesting of Restricted Stock Units and associated tax withholding for August 31, 2025.